Cargando…

Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

SARS-CoV-2 continues to evolve into variants of concern (VOC), with greatest variability in the multidomain, entry-facilitating spike proteins. To recognize the significance of adaptive spike protein changes, we compare variant SARS-CoV-2 virus particles in several assays reflecting authentic virus-...

Descripción completa

Detalles Bibliográficos
Autores principales: Qing, Enya, Li, Pengfei, Cooper, Laura, Schulz, Sebastian, Jäck, Hans-Martin, Rong, Lijun, Perlman, Stanley, Gallagher, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015963/
https://www.ncbi.nlm.nih.gov/pubmed/35477024
http://dx.doi.org/10.1016/j.celrep.2022.110786
_version_ 1784688426428137472
author Qing, Enya
Li, Pengfei
Cooper, Laura
Schulz, Sebastian
Jäck, Hans-Martin
Rong, Lijun
Perlman, Stanley
Gallagher, Tom
author_facet Qing, Enya
Li, Pengfei
Cooper, Laura
Schulz, Sebastian
Jäck, Hans-Martin
Rong, Lijun
Perlman, Stanley
Gallagher, Tom
author_sort Qing, Enya
collection PubMed
description SARS-CoV-2 continues to evolve into variants of concern (VOC), with greatest variability in the multidomain, entry-facilitating spike proteins. To recognize the significance of adaptive spike protein changes, we compare variant SARS-CoV-2 virus particles in several assays reflecting authentic virus-cell entry. Virus particles with adaptive changes in spike amino-terminal domains (NTDs) are hypersensitive to proteolytic activation of membrane fusion, an essential step in virus-cell entry. Proteolysis is within fusion domains (FDs), at sites over 10 nm from the VOC-specific NTD changes, indicating allosteric inter-domain control of fusion activation. In addition, NTD-specific antibodies block FD cleavage, membrane fusion, and virus-cell entry, suggesting restriction of inter-domain communication as a neutralization mechanism. Finally, using structure-guided mutagenesis, we identify an inter-monomer β sheet structure that facilitates NTD-to-FD transmissions and subsequent fusion activation. This NTD-to-FD axis that sensitizes viruses to infection and to NTD-specific antibody neutralization provides new context for understanding selective forces driving SARS-CoV-2 evolution.
format Online
Article
Text
id pubmed-9015963
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors.
record_format MEDLINE/PubMed
spelling pubmed-90159632022-04-19 Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry Qing, Enya Li, Pengfei Cooper, Laura Schulz, Sebastian Jäck, Hans-Martin Rong, Lijun Perlman, Stanley Gallagher, Tom Cell Rep Article SARS-CoV-2 continues to evolve into variants of concern (VOC), with greatest variability in the multidomain, entry-facilitating spike proteins. To recognize the significance of adaptive spike protein changes, we compare variant SARS-CoV-2 virus particles in several assays reflecting authentic virus-cell entry. Virus particles with adaptive changes in spike amino-terminal domains (NTDs) are hypersensitive to proteolytic activation of membrane fusion, an essential step in virus-cell entry. Proteolysis is within fusion domains (FDs), at sites over 10 nm from the VOC-specific NTD changes, indicating allosteric inter-domain control of fusion activation. In addition, NTD-specific antibodies block FD cleavage, membrane fusion, and virus-cell entry, suggesting restriction of inter-domain communication as a neutralization mechanism. Finally, using structure-guided mutagenesis, we identify an inter-monomer β sheet structure that facilitates NTD-to-FD transmissions and subsequent fusion activation. This NTD-to-FD axis that sensitizes viruses to infection and to NTD-specific antibody neutralization provides new context for understanding selective forces driving SARS-CoV-2 evolution. The Authors. 2022-05-03 2022-04-19 /pmc/articles/PMC9015963/ /pubmed/35477024 http://dx.doi.org/10.1016/j.celrep.2022.110786 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Qing, Enya
Li, Pengfei
Cooper, Laura
Schulz, Sebastian
Jäck, Hans-Martin
Rong, Lijun
Perlman, Stanley
Gallagher, Tom
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title_full Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title_fullStr Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title_full_unstemmed Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title_short Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry
title_sort inter-domain communication in sars-cov-2 spike proteins controls protease-triggered cell entry
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015963/
https://www.ncbi.nlm.nih.gov/pubmed/35477024
http://dx.doi.org/10.1016/j.celrep.2022.110786
work_keys_str_mv AT qingenya interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT lipengfei interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT cooperlaura interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT schulzsebastian interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT jackhansmartin interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT ronglijun interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT perlmanstanley interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry
AT gallaghertom interdomaincommunicationinsarscov2spikeproteinscontrolsproteasetriggeredcellentry